Stay updated on Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page.

Latest updates to the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe footerRevision label was updated from v3.6.0 to v3.6.2, indicating a software version upgrade.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedTwo new items were added to the page: 'Check who can join' and 'Find Contact Information', enhancing guidance for potential participants and making it easier to reach support. The revision tag indicates the site is now at v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check24 days agoChange DetectedA new record version (67) with Revision: v3.5.5 was added, updating core sections such as Study Status, Contacts/Locations, and Arms and Interventions. The previous revision (v3.5.4) was removed from the history.SummaryDifference0.3%

- Check45 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a deployment of a new build for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check53 days agoChange DetectedNew history entries add Contacts/Locations, Eligibility, and Study Status to the record, reflecting updates to how the study's sites, eligibility criteria, and current status are tracked. The changes appear in the version history around 2026-04-28 and 2026-05-04, with a deletion noted on 2026-02-23.SummaryDifference0.3%

- Check67 days agoChange DetectedClinicalTrials.gov’s page footer now shows the updated site revision number (from v3.5.2 to v3.5.3), indicating a platform/version update rather than a modification to the study record itself.SummaryDifference0.0%

Stay in the know with updates to Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page.